WVP
VCNX

Worth Venture Partners’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Worth Venture Partners’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-46,720
Closed -$435K – 128
2023
Q4 		$435K Sell
46,720
-4,534
-9% -$53.6K 0.24% 77
2023
Q3 		$811K Buy
51,254
+50,593
+7,654% +$2.57M 0.48% 58
2023
Q2 		$49.4K Hold
661
– – 0.03% 142
2023
Q1 		$55.4K Sell
661
-1,757
-73% -$193K 0.03% 155
2022
Q4 		$335K Hold
2,418
– – 0.2% 92
2022
Q3 		$251K Hold
2,418
– – 0.15% 101
2022
Q2 		$564K Buy
2,418
+2,100
+660% +$537K 0.33% 75
2022
Q1 		$88K Buy
+318
New +$87.9K 0.04% 122

Other funds holding VCNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Worth Venture Partners's VCNX Position: Q1 2024 in Review

Worth Venture Partners sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2024, closing a stake of 46,720 shares — an estimated $435K sold.

Worth Venture Partners first reported a position in VCNX in Q1 2022 and held it in 8 quarters. The position peaked at $811K in Q3 2023. 12 funds tracked by Wall St. Rank hold VCNX as of Q1 2024.

  • Worth Venture Partners reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Worth Venture Partners sold 46,720 Vaccinex, Inc. Common Stock shares in Q1 2024, an estimated $435K.
  • Worth Venture Partners first reported a position in Vaccinex, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Worth Venture Partners's Vaccinex, Inc. Common Stock position peaked at $811K in Q3 2023.
  • 12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2024.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.